Redwood City, California–based Nevro designed HFX iQ for treating chronic pain. The company commenced its full launch after it completed a successful limited market release.
In a news release, Dr. Usman Latif called HFX iQ “the future of medicine.” Latif is an interventional pain specialist at the University of Kansas Medical Center. He added that the platform’s “expanded data holds the promise of new capabilities and improved care.”
About the Nevro HFX iQ system
HFX iQ utilizes the HFX algorithm to select programs most likely to provide pain relief for patients. Nevro built this on more than 20 million data points and 80,000 implanted patients. The system combines clinical inputs like pain relief and pain score to provide an individualized program setting.
Nevro said the system offers both low frequency along with its proprietary high-frequency 10 kHz Therapy. The company said it represents the widest range of frequencies of any SCS system on the market.
HFX iQ features an implantable pulse generator (IPG), trial stimulator and application. It includes a new, Bluetooth-enabled IPG, that offers upgrades and direct connection to the HFX app. Each patient can input assessments into their smartphone and receive adjustments in real-time, Nevro said.
D. Keith Grossman, chair, CEO and president of Nevro, called HFX iQ “the next big advancement to SCS therapy.” He added that it applies data collected over the past decade to find pain relief and maintain that relief over time.
“We are continuing to lead the way with the first big data-backed, AI-powered SCS system that gets smarter over time, learning from patient responses to deliver personalized relief to patients,” said Grossman. “We believe that what we’re doing with HFX iQ is the future of SCS therapy, and keeps Nevro firmly at the forefront of innovation, as we continue to work with our clinicians to bring new technology, new data and new indications to their patients.”
With U.S. approval secured, Nevro said it submitted for further approval in Europe and Australia.
